Nyvepria

Medicinal product

(Invented) name

Nyvepria

Active substance (s)

Pegfilgrastimas

Strength

6 mg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L03AA13, Pegfilgrastim

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2020-11-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	0.6 ml
Pegfilgrastimas	6 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105241	91343	1091343	užpildytas švirkštas	0,6 ml N1 (su adatos apsauga)		Receptinis	EU/1/20/1486/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-11-18	Registruotas